Zobrazeno 1 - 10 of 372 pro vyhledávání: '"MF Good"'
1
Assessment of human cytotoxic T cell activity using synthetic peptides: potential for field application
Autor: Denise Doolan, Ra, Houghten, Mf, Good
Publikováno v: Europe PubMed Central
The use of synthetic peptides to delineate epitopes recognized by major histocompatability complex-restricted cytotoxic T lymphocytes has been well documented. In the present study, we report a method for the generation and assay of peptide-specific
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::200f63648ea7b2cb994afa4cb65b2f0c
https://pubmed.ncbi.nlm.nih.gov/1726648
Zobrazit plný text záznamu
2
T-cell antigenic sites of the malaria circumsporozoite protein
Autor: Sanjai Kumar, Walter R. Weiss, MF Good, Louis H. Miller
Publikováno v: Blood. 74:895-900
Article de synthese en presentant l'importance des lymphocytes T dans l'immunite vis-a-vis du sporozoite. Analyse des epitopes de la proteine du circumsporozoite impliques dans la reconnaissance par les lymphocytes T
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::20066c112f6bf188a4772f779205e8b3
https://doi.org/10.1182/blood.v74.3.895.895
Zobrazit plný text záznamu
3
Human T cell recognition of polymorphic epitopes from malaria circumsporozoite protein
Autor: Annie De Groot, Ah, Johnson, Wl, Maloy, Ia, Quakyi, Em, Riley, Menon A, Sm, Banks, Ja, Berzofsky, Mf, Good
Publikováno v: Europe PubMed Central
Lymphocytes obtained from forty individuals living in a malaria endemic area of West Africa were tested for in vitro proliferative responses to peptides representing variant regions of the immunodominant T cell domain of the circumsporozoite protein
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::59c6781e046a1da51fd2013a88e2573c
https://pubmed.ncbi.nlm.nih.gov/2469729
Zobrazit plný text záznamu
4
Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens
Autor: Ia, Quakyi, Ln, Otoo, Pombo D, Ly, Sugars, Menon A, Annie De Groot, Johnson A, Alling D, Lh, Miller, Mf, Good
Publikováno v: Europe PubMed Central
Synthetic subunit vaccines to sporozoites, merozoites, and gametes are being developed for malaria. The vaccine strategy assumes that the population to be immunized will respond favorably to these vaccine antigens. Using sera of 35 adults and 50 chil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ebd8f60911b2d66af295016938689b30
https://pubmed.ncbi.nlm.nih.gov/2672834
Zobrazit plný text záznamu
6
Akademický článek
Streptococcus pyogenes pharyngitis elicits diverse antibody responses to key vaccine antigens influenced by the imprint of past infections.
Autor: Osowicki J; Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia. joshua.osowicki@rch.org.au.; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia. joshua.osowicki@rch.org.au.; Department of Infectious Diseases, Royal Children's Hospital Melbourne, Melbourne, VIC, Australia. joshua.osowicki@rch.org.au., Frost HR; Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Azzopardi KI; Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Whitcombe AL; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.; School of Medical Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand., McGregor R; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.; School of Medical Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand., Carlton LH; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.; School of Medical Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand., Baker C; Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Fabri L; Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; Microbiology Laboratory, European Plotkin Institute of Vaccinology, Université libre de Bruxelles, Brussels, Belgium.; Department of Paediatrics, Brussels University Hospital, Academic Children Hospital Queen Fabiola, Université libre de Bruxelles, Brussels, Belgium., Pandey M; The Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Good MF; The Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Carapetis JR; Wesfarmers Centre for Vaccines and Infectious Diseases, The Kids Research Institute Australia, University of Western Australia, Perth, WA, Australia.; Faculty of Health and Medical Sciences, University of Western Australia, Perth, WA, Australia.; Department of Paediatric Infectious Diseases, Perth Children's Hospital, Perth, WA, Australia., Walker MJ; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD, Australia.; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD, Australia.; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia., Smeesters PR; Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.; Microbiology Laboratory, European Plotkin Institute of Vaccinology, Université libre de Bruxelles, Brussels, Belgium.; Department of Paediatrics, Brussels University Hospital, Academic Children Hospital Queen Fabiola, Université libre de Bruxelles, Brussels, Belgium., Licciardi PV; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.; Vaccine Immunology Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia., Moreland NJ; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand.; School of Medical Sciences, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand., Hill DL; Department of Immunology, School of Translational Medicine, Monash University, Melbourne, VIC, Australia. danika.hill@monash.edu., Steer AC; Tropical Diseases Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.; Department of Infectious Diseases, Royal Children's Hospital Melbourne, Melbourne, VIC, Australia.
Publikováno v: Nature communications [Nat Commun] 2024 Dec 03; Vol. 15 (1), pp. 10506. Date of Electronic Publication: 2024 Dec 03.
Zobrazit plný text záznamu
7
Akademický článek
Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model.
Autor: Rivera-Hernandez T; Consejo Nacional de Humanidades Ciencia y Tecnología, Unidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City 06720, Mexico.; School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia., Carnathan DG; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA., Richter J; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Marchant P; Vaxcyte Inc., San Carlos, CA 94070, USA., Cork AJ; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Elangovan G; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia., Henningham A; Division of Ob/Gyn & Reproductive Sciences, Vc-Health Sciences-Schools, University of California San Diego, La Jolla, CA 92093, USA., Cole JN; Division of Ob/Gyn & Reproductive Sciences, Vc-Health Sciences-Schools, University of California San Diego, La Jolla, CA 92093, USA., Choudhury B; Division of Ob/Gyn & Reproductive Sciences, Vc-Health Sciences-Schools, University of California San Diego, La Jolla, CA 92093, USA., Moyle PM; School of Pharmacy, The University of Queensland, St. Lucia, QLD 4072, Australia., Toth I; School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia., Batzloff MR; Institute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia., Good MF; Institute for Glycomics, Griffith University, Gold Coast, QLD 4222, Australia., Agarwal P; Vaxcyte Inc., San Carlos, CA 94070, USA., Kapoor N; Vaxcyte Inc., San Carlos, CA 94070, USA., Nizet V; Division of Ob/Gyn & Reproductive Sciences, Vc-Health Sciences-Schools, University of California San Diego, La Jolla, CA 92093, USA., Silvestri G; Emory Vaccine Center, Emory National Primate Research Center, Emory University, Atlanta, GA 30329, USA., Walker MJ; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Publikováno v: Vaccines [Vaccines (Basel)] 2024 Apr 04; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 04.
Zobrazit plný text záznamu
8
Akademický článek
Disruption of IL-17-mediated immunosurveillance in the respiratory mucosa results in invasive Streptococcus pyogenes infection.
Autor: Mills JL; Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Lepletier A; Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Ozberk V; Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Dooley J; Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Kaden J; Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Calcutt A; Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Huo Y; Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Hicks A; School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia., Zaid A; School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia., Good MF; Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia., Pandey M; Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
Publikováno v: Frontiers in immunology [Front Immunol] 2024 Mar 21; Vol. 15, pp. 1351777. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Zobrazit plný text záznamu
9
Akademický článek
A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4 + T-cell-dependent strain-transcending protective immunity in rodent models.
Autor: Okoth WA; Institute for Glycomics, Griffith University, Southport, Queensland, Australia., Ho M-F; Institute for Glycomics, Griffith University, Southport, Queensland, Australia., Zaman M; Institute for Glycomics, Griffith University, Southport, Queensland, Australia., Cooper E; Institute for Glycomics, Griffith University, Southport, Queensland, Australia., Som P; Institute for Glycomics, Griffith University, Southport, Queensland, Australia., Burgess M; Institute for Glycomics, Griffith University, Southport, Queensland, Australia., Walton M; Institute for Glycomics, Griffith University, Southport, Queensland, Australia., Nevagi RJ; Institute for Glycomics, Griffith University, Southport, Queensland, Australia., Beattie L; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia., Murphy D; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia., Stanisic DI; Institute for Glycomics, Griffith University, Southport, Queensland, Australia., Good MF; Institute for Glycomics, Griffith University, Southport, Queensland, Australia.
Publikováno v: MBio [mBio] 2023 Dec 19; Vol. 14 (6), pp. e0254723. Date of Electronic Publication: 2023 Nov 14.
Zobrazit plný text záznamu
10
Akademický článek
Malaria Vaccines: Progress to Date.
Autor: Stanisic DI; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, QLD, Australia. d.stanisic@griffith.edu.au., Good MF; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, QLD, Australia. michael.good@griffith.edu.au.
Publikováno v: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2023 Nov; Vol. 37 (6), pp. 737-756. Date of Electronic Publication: 2023 Sep 20.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje